4//SEC Filing
GIVEN DOUGLAS B 4
Accession 0001628280-24-051924
CIK 0000879407other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 6:18 PM ET
Size
7.4 KB
Accession
0001628280-24-051924
Insider Transaction Report
Form 4
GIVEN DOUGLAS B
Director
Transactions
- Sale
Common Stock
2024-12-17$22.04/sh−547$12,056→ 124,167 total - Sale
Common Stock
2024-12-16$21.90/sh−5,000$109,500→ 124,714 total
Footnotes (4)
- [F1]Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- [F2]Partial disposition of RSUs to satisfy tax withholding obligations.
- [F3]The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $21.64 to $22.20, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
- [F4]Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions.
Documents
Issuer
ARROWHEAD PHARMACEUTICALS, INC.
CIK 0000879407
Entity typeother
Related Parties
1- filerCIK 0001156207
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 6:18 PM ET
- Size
- 7.4 KB